CA - Hovering Around 52-Week Low Bausch + Lomb May Be Poised For A Rebound

2024-01-31 06:23:00 ET

Summary

• Bausch + Lomb is a top company in the global eye health care industry, with over 400 products and operations in over 100 countries.
• The company is focused on its core business of vision care, ophthalmic pharmaceuticals, and surgical equipment.
• Despite being near a 52-week low, Bausch + Lomb is financially stable with a high current ratio and expected growth in revenue and earnings.

I love top players in any industry. It may be a Warren Buffett thing, but I like nothing more than to invest in companies that stand astride their industry like a colossus. Sure, there's competition for everyone, but being a market leader comes with a certain expertise and respect that it's tough to buy....

For further details see: